Report cover image

Strategic Intelligence: Precision and Personalized Medicine - Advanced Therapeutics

Publisher GlobalData
Published Feb 27, 2026
Length 60 Pages
SKU # GBDT21015607

Description

Strategic Intelligence: Precision and Personalized Medicine - Advanced Therapeutics

Summary

Precision and personalized medicine (PPM) has already begun to reshape disease treatment paradigms and the provision of healthcare.

Gene-modified cell therapies are emerging as a cornerstone modality within PPM.

Cell therapies are entering a rapid growth phase across oncology and regenerative medicine.

Gene therapy remains a blockbuster-led modality with expanding therapeutic reach.

Antisense oligonucleotides are emerging as a fast-growing modality within PPM.

Oncolytic virus therapies show emerging commercial traction but remain a niche modality.

Core precision medicine enablers are strengthening adoption.

Scope
  • This report talks about how precision and personalized medicine (PPM) has already begun to reshape disease treatment paradigms and the provision of healthcare.
  • Improved patient outcomes, increased quality of life, reduced financial and time expenditure of disease management with curative therapies, and a shift from reactive to proactive care are all driving investment in R&D in this space.

Table of Contents

60 Pages
Executive Summary
Introduction
Market Overview
Gene-Modified Cell Therapies
Cell Therapies
Gene Therapies
Antisense Oligonucleotides
Oncolytic Viruses
Case Studies
Important Factors to Consider
CGT Market
Genomics
Biomarkers
Key Takeaways
Appendix

Search Inside Report

How Do Licenses Work?
Request A Sample
Head shot

Questions or Comments?

Our team has the ability to search within reports to verify it suits your needs. We can also help maximize your budget by finding sections of reports you can purchase.